JobWatch is a job posting and career development site designed exclusively for clinical research professionals of all levels. Job seekers can easily post and update resumes, apply directly for open positions and register for e-mail alerts announcing new positions. It is also the perfect resource to learn more about upcoming conferences on clinical research-related topics or register for training and academic degree programs for career development and advancement.
Sign up for your free account and find your next opportunity today!
Reach more professionals with your job posting. Jobs posted on JobWatch also appear complementary on ACRPs Career Center as part of our partnership. Your job listing receives extra exposure to the industry's largest community of clinical research professionals. Post Jobs Today.
Alnylam Pharmaceuticals, an RNAi therapeutics company, has announced the expansion of its global footprint with the opening of a new development and commercial hub in Maidenhead, U.K. In anticipation of substantial growth across Alnylam over the next five years, the office opens with a core clinical development, regulatory affairs and commercial team and space for an additional 100 employees.
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has announced the launch of the Eisai Andover innovative Medicines (AiM) Institute, a discovery innovation unit within the greater Boston biopharma hub. With 90 integrated scientists at a state-of-the-art research facility in Andover, Massachusetts, the Institute is focused on executing novel therapeutic targets validated by human genetics and related data to discover and develop precision medicines for some of the hardest-to-treat medical conditions including dementia, cancer and auto-immune diseases.
GSK has announced that Emma Walmsley, currently chief executive officer (CEO) of GSK’s Consumer Healthcare division, has been appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO when he retires on March 31, 2017. Walmsley will join the GSK board of directors January 2017.
Congressman Michael Mccaul and Congressman Chris Van Hollen to be honored at the 3rd Annual Golden Toast. The Golden Toast represents bipartisan politics at its finest. It is an evening when members of Congress from both sides of the aisle demonstrate a commitment to some of the most vulnerable members of society—children who are fighting cancer. In an election season marked by divisiveness, the Golden Toast is a visible reminder that our elected officials can put aside disagreements to accomplish meaningful change and advance life-saving research.